Total scores on MMSE and CDT clinical scales used for assessing the cognitive deficits were similar among patients carrying different BDNF Val66Met genotypes, indicating a lack of association of BDNF Val66Met polymorphism and cognitive decline in individuals with MCI and dementia (Table 6). The gene discussed is BDNF; the disease is Cognitive impairment.